Drugs
Gemzar
Generic Name: Gemcitabine hydrochloride
Product Name: Gemzar
- Indication of Gemzar
- Action of Gemzar
- Dose advice of Gemzar
- Schedule of Gemzar
- Common side effects of Gemzar
- Uncommon side effects of Gemzar
- Reference
Indication of Gemzar:
Treatment of the following locally advanced, metastatic or non responsive cancers:- Non-small cell lung cancer- Pancreatic adenocarcinoma- Bladder cancer- Breast cancer- Ovarian carcinomaAction of Gemzar:
Gemciabine targets and kills cancer cells. It does this by damaging the DNA within the cell rendering it incapable of dividing.Dose advice of Gemzar:
Gemcitabine is administered intravenously.The dose and administration regime varies with cancer type, combination therapy, hepatic and renal insufficiency and age of the patient.In general, a dose of approximately 1,000 mg/m2 is given over a 30-minute period. This is repeated weekly or monthly during the designated treatment period.Gemcitabine may cause drowsiness, do not drive or operate heavy machinery if affected.Schedule of Gemzar:
S4Common side effects of Gemzar:
- Low platelet and immune cell count.- Anaemia.- Drowsiness.- Shortness of breath.- Nausea.- Vomiting.- Diarrhoea.- Constipation.- Allergic skin rash.- Hair loss.- Itchness.- Ulceration of mucous membrane of the mouth.- Blood or protein in the urine.- Swelling.- Flu like symptoms.- Fever.- Weakness.- Raised Liver function tests.Uncommon side effects of Gemzar:
- Allergic reactions.- Heart failure or arrhythmia.- Low blood pressure.- Lung dysfunction.- Changes in the skin.- Kidney failure.- Cough.- Colds.- Perspiration.- Sleeping difficulties.Reference:
[1] MIMS Australia Pty Ltd [online]. Gemzar. MediMedia: NSW; 2005.Diseases treated by Gemzar:
- Breast Cancer (Carcinoma of the Breast)
- Breast Cancer (Pre-Invasive Ductal Carcinoma; Ductal Carcinoma In Situ; DCIS)
- Lung Cancer (Adenocarcinoma of the Lung)
- Pancreatic Cancer (Adenocarcinoma of the Pancreas)
For further information talk to your doctor.
Article Dates:
|
|







